Literature DB >> 3009060

A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.

I Ando, G Morgan, R J Levinsky, D H Crawford.   

Abstract

The X-linked lymphoproliferative syndrome (XLPS) is an immunodeficiency characterized by severe primary infection with the Epstein Barr (EB) virus, which is often fatal. This has been attributed to failure to generate T lymphocytes which are specifically cytotoxic for EB virus-infected B lymphocytes, and which develop in all normal individuals following primary infection. We have studied a kindred which carried the defective gene for XLPS and have confirmed that the pattern of serum antibody responses to EB viral antigens can be used to detect affected males and female carriers. Furthermore, an EB virus genome-carrying B cell line which grew spontaneously from a culture of bone marrow cells from a male child with XLPS at the time of primary infection showed a decreased sensitivity to MHC-restricted, EB virus-specific killing by a T cell clone when compared to its in vitro EB virus-transformed counterpart. From these results we suggest that a subset of EB virus-infected B lymphocytes which were resistant to EB virus-specific killing existed in this child, and may have contributed to the overwhelming EB virus infection and its fatal outcome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009060      PMCID: PMC1577368     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Epstein-Barr herpesvirus and infectious mononucleosis.

Authors:  G Miller
Journal:  Prog Med Virol       Date:  1975

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis.

Authors:  G Henie; W Henle; C A Horwitz
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

4.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

7.  Quantitative in vitro assay of cytotoxic cellular immunity.

Authors:  T G Canty; J R Wunderlich
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

8.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

9.  Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.

Authors:  C M Rooney; A B Rickinson; D J Moss; G M Lenoir; M A Epstein
Journal:  IARC Sci Publ       Date:  1985

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  4 in total

1.  X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.

Authors:  A Harris; J Collins; D Vetrie; C Cole; M Bobrow
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.

Authors:  M Yanagisawa; M Kato; K Ikeno; T Kobayashi; Y Miyagawa; A Komiyama; T Akabane
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection.

Authors:  P Morgan-Capner; J A Morris; M B McIllmurray; J A Thomas; D H Crawford; T Azim
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

4.  X linked lymphoproliferative disease in a United Kingdom family.

Authors:  P D Arkwright; G Makin; A M Will; M Ayres; D A Gokhale; W D Fergusson; G M Taylor
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.